| 期 |
栏目 |
标题 |
文件 |
| 卷 160, 编号 5 (2016) |
Article |
Chromogranin As a Biochemical Marker of Neuroendocrine Tumors |
|
| 卷 160, 编号 6 (2016) |
Article |
Regulatory Proteins of Epithelial-Mesenchymal Transition and Some Components of VEGF Signaling Pathway in Breast Cancer |
|
| 卷 162, 编号 6 (2017) |
Article |
Role of Methylation in the Regulation of Apoptosis Genes APAF1, DAPK1, and BCL2 in Breast Cancer |
|
| 卷 163, 编号 2 (2017) |
Oncology |
Association between the Prevalence of Somatic Mutations in PIK3CA Gene in Tumors and Clinical and Morphological Characteristics of Breast Cancer Patients |
|
| 卷 163, 编号 4 (2017) |
Article |
Specific Localization of Missense Mutations in the VHL Gene in Clear Cell Renal Cell Carcinoma |
|
| 卷 163, 编号 4 (2017) |
Article |
Receptor Activator of Nuclear Transcription Factor NF-κB (RANK), Its Ligand RANKL, and Natural Inhibitor of RANKL Osteoprotegerin (OPG) in the Blood Serum of Patients with Primary Bone Tumors |
|
| 卷 163, 编号 4 (2017) |
Experimental Methods for Clinical Practice |
Free Immunoglobulin Light Chains as Criteria of Extracorporeal Hemocorrection in Patients with Monoclonal Gammopathies |
|
| 卷 163, 编号 5 (2017) |
Oncology |
Search of MicroRNAs Regulating the Receptor Status of Breast Cancer In Silico and Experimental Confirmation of Their Expression in Tumors |
|
| 卷 164, 编号 3 (2018) |
Oncology |
Five Hypermethylated MicroRNA Genes as Potential Markers of Ovarian Cancer |
|
| 卷 164, 编号 6 (2018) |
Supplement |
Circular RNA: New Regulatory Molecules |
|
| 卷 165, 编号 1 (2018) |
Oncology |
Matrix Metalloproteinases and Their Tissue Inhibitors in Blood Serum of Patients with Endometrial Cancer: Clinical and Morphological Correlations |
|
| 卷 165, 编号 1 (2018) |
Article |
Immunochemical Diagnosis of Multiple Myeloma |
|
| 卷 165, 编号 1 (2018) |
Article |
Loss of Heterozygosity in BRCA1 and BRCA2 Genes in Patients with Ovarian Cancer and Probability of Its Use for Clinical Classification of Variations |
|
| 卷 165, 编号 5 (2018) |
Article |
Expression of microRNA Potentially Regulated by AhR and CAR in Malignant Tumors of the Endometrium |
|
| 卷 166, 编号 3 (2019) |
Article |
Soluble Ligand of the Immune Checkpoint Receptor (sPD-L1) in Blood Serum of Patients with Renal Cell Carcinoma |
|
| 卷 166, 编号 3 (2019) |
Oncology |
Clinical Significance of Matrix Metalloproteinases in Blood Plasma of Patients with Gastric Cancer |
|
| 卷 166, 编号 4 (2019) |
Oncology |
Analysis of Anti-Glycan IgG and IgM Antibodies in Colorectal Cancer |
|
| 卷 167, 编号 1 (2019) |
Oncology |
Hypermethylated Genes of MicroRNA in Ovarian Carcinoma: Metastasis Prediction Marker Systems |
|
| 卷 167, 编号 1 (2019) |
Article |
Comparative Analysis of Blood Plasma Proteome in Patients with Renal Cell Carcinoma |
|
| 卷 167, 编号 3 (2019) |
Oncology |
Kidney Injury Molecule-1 (KIM-1) in Blood Plasma of Patients with Clear-Cell Carcinoma |
|
| 卷 168, 编号 2 (2019) |
Article |
Marker Systems Based on MicroRNA Gene Methylation for the Diagnosis of Stage I-II Breast Cancer |
|
